Profound Medical (PRN) to Release Quarterly Earnings on Thursday

Profound Medical (TSE:PRN) is scheduled to post its quarterly earnings results after the market closes on Thursday, May 9th. Analysts expect Profound Medical to post earnings of C($0.41) per share for the quarter.

Profound Medical (TSE:PRN) last released its earnings results on Thursday, March 7th. The company reported C($0.57) earnings per share for the quarter, missing analysts’ consensus estimates of C($0.38) by C($0.19). The company had revenue of C$2.74 million during the quarter, compared to the consensus estimate of C$2.56 million.

Profound Medical Trading Up 1.8 %

Shares of PRN stock opened at C$10.22 on Wednesday. The company has a debt-to-equity ratio of 25.47, a current ratio of 6.58 and a quick ratio of 14.98. Profound Medical has a 1-year low of C$9.55 and a 1-year high of C$20.44. The business has a 50-day moving average of C$11.10 and a 200 day moving average of C$11.72. The stock has a market capitalization of C$16.97 million, a PE ratio of -5.58 and a beta of 1.24.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.